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Abstract  
To predict if developing human embryos are permissive to coronaviruses, we analyzed publicly 
available single cell RNA-seq datasets of zygotes, 4-cell, 8-cell, morula, inner cell mass, epiblast, 
primitive endoderm and trophectoderm for the coronavirus receptors (ACE2, BSG, DPP4 and 
ANPEP), the Spike protein cleavage enzymes (TMPRSS2, CTSL). We also analyzed the presence of 
host genes involved in viral replication, the endosomal sorting complexes required for transport 
(ESCRT) and SARS-Cov-2 interactions. The results reveal that ACE2, BSG, DPP4 and ANPEP are 
expressed in the cells of the zygote, to blastocyst including the trophectodermal lineage. ACE2, 
TMPRSS, BSG and CTSL are co-transcribed in a proportion of epiblast cells and most cells of the 
trophectoderm. The embryonic and trophectodermal cells also express genes for proteins ESCRT, 
viral replication and those that interact with SARS-CoV-2. We identified 1985 genes in epiblast and 
1452 genes in the trophectoderm that are enriched in the ACE2 and TMPRSS2 co-expressing cells; 
216 genes of these are common in both the cell types. These genes are associated with lipid 
metabolism, lysosome, peroxisome and oxidative phosphorylation pathways. Together our results 
suggest that developing human embryos could be permissive to coronavirus entry by both canonical 
and non-canonical mechanisms and they also express the genes for proteins involved in viral 
endocytosis and replication. This knowledge will be useful for evidence-based patient management 
for IVF during the COVID-19 pandemic. 
Keywords: Virus, Coronavirus, SARS-CoV-2, COVID-19, receptors, replication, interaction, 
embryo, human, in vitro fertilization, single-cell RNA-Seq  
 
 
3 
 
Introduction 
Infection with the novel coronavirus, Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-
CoV-2) causes Coronavirus Disease 2019 (COVID-19) in humans, (Singhal, 2020) and the virus has 
spread worldwide and infected millions of individuals including pregnant women. Perinatal 
infections including with coronaviruses can cause maternal and fetal illness and account for 2-3% of 
all congenital abnormalities (Silasi et al., 2015; Racicot and Mor, 2017; Di Mascio et al., 2020). 
Like most viruses, the coronaviruses enter host cells by receptor binding followed by endocytosis, 
genome replication, exocytosis, and budding. Human Angiotensin-Converting Enzyme II (ACE2) is 
the host receptor specific to SARS-CoV-2 (Letko et al., 2020) and the S protein of the virus binds to 
ACE2 with high affinity (Jagtap et al., 2020; Shang et al., 2020a, 2020b). SARS-CoV-2 does not use 
other coronavirus receptors viz; alanine aminopeptidase N (ANPEP) and dipeptidyl peptidase 4 
(DPP4), which are used by CoV-229E and the Middle East Respiratory Syndrome Coronavirus 
(MERS-CoV), respectively, for entry into host cells (Li, 2015; Letko et al., 2020). In addition to 
ACE2, SARS-CoV-2 utilizes Basigin (BSG), also known as CD147, as an alternate receptor for viral 
entry (Wang et al., 2020). The binding of the virus to the host receptors occurs via the SARS-CoV-2 
spike (S) protein that is processed by a range of host proteases (Hoffmann et al., 2020; Shang et al., 
2020a) like transmembrane serine protease 2 (TMPRSS2), TMPRSS4, FURIN, and cathepsin L 
(CTSL). The host receptors and S protein processing enzymes are collectively referred to as SARS 
coronavirus-associated receptors and factors (SCARFs), and their co-expression in the tissues is the 
determinant of susceptibility to SARS-CoV-2 infection (Singh et al., 2020b). SCARFs are expressed 
in a variety of human tissues such as the airway and alveolar epithelium, oral and nasal mucosa, 
nasopharynx, stomach, small intestine, colon, skin, lymph nodes, thymus, bone marrow, spleen, 
liver, kidney, and placenta (Lukassen et al., 2020; Qi et al., 2020; Seow et al., 2020; Singh et al., 
2020b; Xu et al., 2020).  
Epidemiologic and clinical evidence suggests that pregnant women are at higher risk of severe illness 
and mortality from viral infections, which can lead to several adverse outcomes such as spontaneous 
abortion, intrauterine fetal deaths, still-births, and mother-to-child transmission resulting in 
congenital viral syndromes (Silasi et al., 2015; Racicot and Mor, 2017; Adams Waldorf et al., 2018). 
In pregnant women, COVID-19 is associated with severe pregnancy complications such as preterm 
labor and premature rupture of membranes (Gajbhiye et al., 2020; Knight et al., 2020). A small but 
significant proportion of women with COVID-19 experience still-births or intrauterine fetal death, 
and there is evidence of vertical transmission of the virus through the placenta (Bahadur et al., 2020; 
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Gajbhiye et al., 2020; Hosier et al., 2020; Knight et al., 2020; Verma et al., 2020; Vivanti et al., 
2020). Indeed, SCARFs are expressed in the trophoblast cells (Ashray et al., 2020; Li et al., 2020a; 
Singh et al., 2020b) suggesting that the placenta may be permissive to SARS-CoV-2 infection. 
Beyond the adult tissues, viruses can also infect gametes and developing embryos (Racicot and Mor, 
2017). It has been recently shown that Zika virus can infect and propagate in the trophectodermal 
cells of preimplantation human, rhesus monkey, and mouse embryos, causing death of neural 
progenitors leading to microcephaly and miscarriage (Tan et al., 2019; Block et al., 2020). Thus, 
studies on preimplantation mammalian embryos are important because viral infections during early 
pregnancy can induce embryonic death or abnormal embryonic development (Hardy, 1974; Silasi et 
al., 2015; Tan et al., 2019; Block et al., 2020). With the high population spread and the observation 
that a large proportion of individuals with SARS-CoV-2 infection may be asymptomatic, (Bharti et 
al., 2020; Hao et al., 2020; Kaur et al., 2020; Kissler et al., 2020; Li et al., 2020b) it is likely that 
many women may have conceived during the course of subclinical infection. Secondly, many 
assisted reproduction clinics may have handled human gametes and embryos from sub-clinically 
infected couples or inadvertently exposed them to infected laboratory personnel. Given the fact that 
SARS-CoV-2 has a high surface stability on various materials (Ong et al., 2020; van Doremalen et 
al., 2020), there can be many potential routes by which gametes/embryos could be exposed to SARS-
CoV-2. However, whether the human gametes or early embryos are permissive to SARS-CoV-2 or 
other coronaviruses remains unknown.   
As a preamble towards our understanding of the potential effects of SARS-CoV-2 in early 
pregnancy, we analysed publicly available single-cell RNA-Seq datasets of human embryos to 
determine the expression of SCARFs in the zygote to late-blastocyst-stage human embryos. In 
addition, we determined whether endocytotic and viral replication machinery are also expressed by 
the cells of early embryos. 
 
Materials and Methods 
To understand the expression of SCARFs in various cells of the embryo (zygote to late blastocysts), 
single-cell RNA-Seq datasets (Petropoulos et al., 2016; Stirparo et al., 2018) were analysed. The 
dataset by Stirparo et al. was chosen as it contained uniformly analysed samples from the three 
published studies (Yan et al., 2013; Blakeley et al., 2015; Petropoulos et al., 2016) and recapitulated 
the known lineage markers of zygote to late blastocyst embryos. It allows an in-depth exploration of 
the transcriptome of multiple cells in the inner cell mass (ICM), epiblast, and primitive endoderm. 
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The dataset from Petropoulos et al., 2016 (accession number: E-MTAB-3929 allowed in-depth 
exploration of the largest numbers of trophectodermal cells from day 5 to day 7 blastocysts of in 
vitro fertilization. Table 2 and Table 3 give the number of embryos and the total number of cells 
tested at each time point of embryonic development.   
The percentage of ACE2, BSG, TMPRSS2, CTSL, DPP4, and ANPEP expressing cells were obtained 
for each cell at each stage; the percentage of cells co-expressing ACE2 and BSG, ACE2 and 
TMPRSS2, ACE2 and CTSL, and BSG and CTSL were also estimated for each cell type. The list of 
genes representing protein products involved in the Endosomal Sorting Complex Required for 
Transport (ESCRT I, II, and III) and SARS virus replication in host cells were obtained (de Wilde et 
al., 2018; Ahmed et al., 2019), and their mRNA levels in cells of the zygote to blastocyst (including 
trophectoderm) were extracted. In addition, the data containing mRNA levels of 332 proteins that 
physically interact with SARS-CoV-2 (Gordon et al., 2020) were extracted.  
We aimed to identify the gene signatures associated with ACE2+TMPRSS2+ cells in the developing 
embryos. Pseudo-bulk analysis of single-cell data of the epiblast and trophectodermal lineage on day 
7 was carried out for ACE2- and TMPRSS2-positive (ACE2+TMPRSS2+) and ACE2- and 
TMPRSS2-negative (ACE2–TMPRSS2–) cells. The epiblast cells and day 7 trophectoderm cells were 
chosen as they had a reasonable proportion of both ACE2+TMPRSS2+ co-expressing cells versus 
those that did not express either. This allowed us to have enough numbers of cells in both groups to 
reasonably apply statistical testing. For pseudo-bulk analysis, the mean values of all the genes 
expressed in the ACE2+TMPRSS2+ and ACE2–TMPRSS2– cells were computed. Genes that had a 
ratio of >1.5 or <0.5 were filtered. Welch’s t-test was applied and genes that had significantly 
different mean values (p<0.05) were filtered.  
The Gene Ontologies (GO) associated with the differentially expressed genes in ACE2- and 
TMPRSS2-positive cells were obtained using gProfiler (https://biit.cs.ut.ee/gprofiler/gost). Categories 
with Benjamini-Hochberg False Discovery Rate [FDR] <0.05 were considered as enriched. The 
terms were selected based on negative_log10_of_adjusted_p_value. Pseudo-bulk and deconvoluted 
single-cell data were visualized using Morpheus (https://software.broadinstitute.org/morpheus) and R 
Studio version 3.6.2 with the Seurat and ggplot2 packages (RStudio Team (2020). RStudio: 
Integrated Development for R. RStudio, PBC, Boston, MA http://www.rstudio.com/).   
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Results 
mRNA levels of coronavirus-associated genes ACE2, TMPRSS2, BSG, CTSL, DPP4, and 
ANPEP in early stages of human embryonic development 
Table1. summarizes the receptors used by the various coronaviruses known to infect humans. As 
evident from Fig.1 ACE2 mRNA was detected in the zygotes, which decreased until the morula stage 
and subsequently increased in the ICM, epiblast, and the primitive endoderm. Almost all cells of the 
trophectoderm of day 5 and day 6 embryos expressed ACE2, and the numbers of cells and transcript 
abundance of ACE2 declined in trophectoderm of day 7 blastocysts. 
 
Virus Human host receptor 
SARS-CoV-2 ACE2, CD147 (BSG) 
SARS-CoV ACE2, CD147 (BSG) 
MERS-CoV DPP4 
HCoV-OC43 9-O-acetylsialic acids 
HCoV-HKU1 9-O-acetylsialic acids 
HCoV-229E ANPEP 
CoV-NL63 ACE2 
 
BSG mRNA was consistently detected in all stages of embryonic development with an increase in 
expression from the zygote to blastocyst stage (Fig. 1). Almost all the trophectodermal cells of the 
day 5-7 blastocysts expressed BSG mRNA (Fig. 1). 
TMPRSS2 was not detected in the zygotes, and very few TMPRSS2-positive cells were detected until 
the blastocyst stage. The highest mRNA levels of TMPRSS2 were observed in epiblast cells, but their 
numbers were lower in the primitive endoderm (Fig. 1). Abundant TMPRSS2 was detected in most of 
the trophectodermal cells of day 5-7 blastocysts (Fig. 1).  
A low abundance of CTSL mRNA was observed in the zygotes and 4- and 8-cell embryos, but its 
levels increased in all the cells of the morula, ICM, epiblast, and primitive endoderm (Fig. 1). CTSL 
mRNA was expressed in most trophectodermal cells of the day 5-7 embryos (Fig. 1). 
Table 1: Summary of host receptors of coronaviruses that infect humans 
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Fig.1. mRNA expression of coronavirus receptors and spike protein processing enzymes in 
early human embryos. (A) X axis represents various stages of development from zygote to 
blastocysts and Y axis represents FPKM values. (B) X axis represents trophectoderm of day 5 to day 
7 and Y axis represents RPKM value. Each dot represents expression of mRNA in single cell. ACE2 
and BSG are the receptors for SARS-CoV-2 and SARS-CoV, DPP4 is the receptor for MERS-CoV, 
and ANPEP is the receptor for HCoV-229E. The viral spike protein is processed by host enzymes 
TMPRSS2 or CTSL. scRNAseq data for embryonic cells (in A) was extracted from (Stirparo et al., 
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2018) while that of trophectodermal cells on different days of embryonic development (in B) was 
extracted from (Petropoulos et al., 2016).  
 
DPP4 and ANPEP mRNA was not detected in the zygote and 4- and 8-cell embryos; however, 
abundant DPP4 and ANPEP transcripts were detected in the cells of the morula, ICM, epiblast, and 
primitive endoderm (Fig.1). Both DPP4 and ANPEP were also abundantly expressed in 
trophectodermal cells of day 5-7 blastocysts (Fig. 1).  
 
Co-expression of transcripts of SARS-CoV-2 receptors and processing enzymes in early stages 
of human embryonic development 
We next determined the numbers of cells at different stages of embryonic development that co-
express transcripts of ACE2 and TMPRSS2. Cells of the zygote, 4- and 8-cell, and morula stage 
embryos did not co-express ACE2 and TMPRSS2. A small proportion of cells in the ICM and 
primitive endoderm co-expressed ACE2 and TMPRSS2, and the largest proportion (34%) of ACE2 
and TMPRSS2 co-expressing cells were detected in the epiblast (Fig. 2). In the trophectodermal 
lineage, the day 5 blastocysts had 77% (110/142) and day 6 blastocysts had 83% (275/331) of cells 
co-expressing ACE2 and TMPRSS2. The numbers of ACE2 and TMPRSS2 double-positive 
trophectodermal cells declined to 33% (129/388) in day 7 blastocysts (Fig. 3).  
We also determined the co-expression of ACE2 and CTSL, ACE2 and BSG, and BSG and CTSL in 
single cells of developing human embryos. The results reveal that all the zygotes and all cells of the 
4- cell stage co-expressed ACE2 and BSG (Fig. 2). In the ICM, around 86% (37/43) of cells co-
expressed ACE2 and BSG; 39% (25/64) of the cells of the epiblast and 39% (11/28) of the cells of 
the primitive endoderm co-expressed ACE2 and BSG (Table 2). Most trophectodermal cells of day 5 
and day 6 blastocysts co-expressed ACE2 and BSG (Fig. 3); on day 7, the number of trophectodermal 
cells co-expressing ACE2 and BSG declined to 38% (149/388)(Table 3). 
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Table 2: Numbers and percentage of cells expressing ACE2+TMPRSS2+, ACE2+BSG+, 
ACE2+CTSL+, BSG+CTSL+ in human embryos at different stages. Data was extracted from single-
cell RNA-Seq of the epiblast of developing human embryos (Stirparo et al 2018).  The total cells and 
the numbers of embryos analysed are also given. 
 
 
Table 3: Numbers and percentages of cells expressing ACE2+TMPRSS2+, ACE2+BSG+, 
ACE2+CTSL+, and BSG+CTSL+ in trophectoderm of human embryos at different stages, as well as 
total numbers of cells and embryos analysed. Data were extracted from single-cell RNA-Seq of 
trophectoderm (Petropoulos et al., 2016, accession no. E-MTAB-3929). 
 ACE2+ 
TMPRSS2+ 
ACE2+ 
BSG+ 
ACE2+ 
CTSL+ 
BSG+ 
CTSL+ 
Total Cells 
Analysed 
Total 
Embryos 
Analysed 
Day 5 110 (77%) 140 (99%) 140 (99%) 142 (100%) 142 18 
Day 6 275 (83%) 290 (88%) 290 (88%) 330 (100%) 331 17 
Day 7 129 (33%) 149 (38%) 149 (38%) 388 (100%) 388 17 
 
 
 ACE2+ 
TMPRSS2+ 
ACE2+ 
BSG+ 
ACE2+ 
CTSL+ 
BSG+ 
CTSL+ 
Total Cells 
Analysed 
Total 
Embryos 
Analysed 
Zygote 0 (0%) 3 (100%) 3 (100%) 3 (100%) 3 3 
4-Cell Stage 0 (0%) 10 (100%) 10 (100%) 10 (100%) 10 3 
8-Cell Stage 0 (0%) 5 (31%) 5 (31%) 16 (100%) 16 3 
Morula 0 (0%) 3 (10%) 3 (10%) 29 (100%) 29 3 
Inner Cell 
Mass 
5 (12%) 37 (86%) 37 (86%) 43 (100%) 43 3 
Epiblast 22 (34%) 25 (39%) 25 (39%) 64 (100%) 64 12 
Primitive 
Endoderm 
6 (21%) 11 (39%) 11 (39%) 28 (100%) 28 12 
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ACE2 and CTSL were co-expressed in the zygotes and all the cells of 4-cell stage embryos, 31% of 
cells in the 8-cell stage, and 10% of the cells in the morula. Around 86% (37/43) of ICM, 39% 
(25/64) of epiblast, and 39% (11/28) of primitive endoderm cells co-expressed ACE2 and CTSL (Fig. 
2). In the trophectoderm, 99% (140/142), 88% (290/331), and 38% (149/388) of trophoblasts from 
day 5, 6, and 7 blastocysts co-expressed ACE2 and CTSL (Fig. 3). 
BSG and CTSL co-expressing cells were observed at all stages of development. All the cells of the 
ICM (43/43), epiblast (64/64), and primitive endoderm (28/28) co-expressed BSG and CTSL (Fig. 2). 
In the trophectodermal lineage, 100% (142/142) of day 5, 330/331 day 6, and 100% (388/388) of day 
7 blastocysts co-expressed BSG and CTSL (Fig. 3). 
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Fig.2. Co-expression of mRNA of SARS-CoV-2 receptors and spike protein processing enzymes 
during early stages of embryonic development. 
Co-expression of ACE2 and TMPRSS2, ACE2 and BSG, ACE2 and CTSL, and BSG and CTSL in 
single cells of human embryos at zygote, 4 cell, 8 cell, compact morula, early inner cell mass (ICM) 
epiblast and primitive endoderm. Blue dot represents expression of both the transcripts plotted on X 
as well Y axis, red dot represents expression of only one transcript plotted on X axis and magenta dot 
represents expression of only one transcript plotted on Y axis. The numbers in each graph represents 
percentage (%) of co-expressing cells. Data was extracted from single-cell RNA-Seq of developing 
human embryos (Stirparo et al., 2018). 
 
 
Fig.3 Co-expression of mRNA of SARS-CoV-2 receptors and spike protein processing enzymes 
in trophectoderm lineage at day 5 to day 7. Co-expression of ACE2 and TMPRSS2, ACE2 and 
BSG, ACE2 and CTSL, and BSG and CTSL in trophectoderm of human embryo. Blue dot represents 
expression of both the transcripts, red and magenta dot represents expression of only one transcript. 
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The numbers in each graph represents percentage (%) of co-expressing cells. Data was extracted 
from single-cell RNA-Seq of trophectoderm of day 5-7 blastocysts (Petropoulos et al., 2016). 
mRNA levels of genes involved in viral endocytosis and replication in human embryos at 
different stages of development.  
We next hypothesized that if the virus can bind to the embryonic cells, the embryos may express the 
cellular machinery necessary for viral endocytosis and viral replication. Towards this, we analysed 
mRNA levels of the 33 genes involved in the human ESCRT of viruses. The pseudo-bulk analysis 
revealed that from the zygote to the morula stage, the mRNA for most of the ESCRT genes is 
undetected or present in low abundance. However, the transcripts for almost 90% of these genes 
dramatically increased in the ICM, epiblast, and primitive endoderm. Additionally, almost all the 
genes were expressed in high abundance in the trophectodermal lineage of day 5-7 embryos (Fig.4).  
Coronaviruses enter the cells and utilizes the host cell machinery for replication. We determined the 
mRNA levels for host genes involved in SARS-CoV replication by pseudo-bulk analysis and 
observed that the mRNA of genes representing protein products involved in viral replication was not 
expressed or was present in low abundance from the zygote to morula stages of embryonic 
development. However, the mRNA levels of most of these genes surged in the ICM, epiblast, and the 
primitive endoderm, and maximal expression of almost all these genes was observed in the 
trophectodermal cells of day 5-7 embryos (Fig. 4).  
SARS-CoV-2 interacts with 332 proteins in human cells. Transcripts for only a few of these genes 
were abundant; most were weakly expressed in the zygote, 4- and 8-cell, morula, and ICM stages as 
evident by pseudo-bulk analysis. However, many cells of the epiblast and primitive endodermal 
lineage expressed the mRNA for these genes. Almost all the cells of the trophectodermal lineage of 
day 5-7 blastocysts expressed mRNA encoding for the proteins that interact with SARS-CoV-2 
(Fig4).  
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Analysis of individual cells of the epiblast and day 7 blastocyst, which had proportions of ACE2 and 
TMPRSS2 co-expressing cells (most permissive to SARS-CoV-2 infection), revealed that almost all 
the genes representing protein products involved in ESCRT, viral replication, and SARS-CoV-2 
interaction were expressed with minimal cell-to-cell heterogeneity (Supplementary Fig 1). Similar 
results were observed for day 5 and day 6 blastocysts (not shown).  
  
Fig.4. mRNA levels of genes involved in viral endocytosis and replication in human embryos at 
different stages of development. Pseudo-bulk data for the mRNA levels of genes involved in (A) 
Endosomal Complexes Required for Transport (ESCRT), (B) viral replication and (C) SARS-CoV-2 
interactions. All data were extracted from single-cell RNA-Seq of developing human embryos 
(Stirparo et al., 2018) and from trophectoderm cells from (Petropoulos et al., 2016) In all heat maps, 
each row depicts a gene and each column depicts a stage of embryonic development. Data is 
presented in relative color scale.  
Differentially expressed genes and the biological processes enriched in ACE2 and TMPRSS2 
co-expressing cells of the epiblast and trophectodermal cells of day 7 blastocysts. 
In the epiblast, 34% of cells co-expressed ACE2 and TMPRSS2 while the others did not express 
either ACE2 or TMPRSS2 (Table 2). By pseudo-bulk analysis, we identified 1985 genes that were 
differentially expressed (fold change >1.5 or <0.5) with statistical significance (p-value <0.05) 
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between ACE2- and TMPRSS2-positive cells and ACE2- and TMPRSS2-negative cells of the 
epiblast. Fig. 5 depicts the deconvolution of these 1985 differentially expressed genes in single cells 
of the epiblast. As compared to ACE2- and TMPRSS2-negative cells, nearly 67% (1323/1985) of 
genes were present at a higher abundance in the ACE2- and TMPRSS2-positive cells of the epiblast. 
While there was cell-to-cell heterogeneity in expression of the differentially abundant genes in the 
ACE2–TMPRSS2– cells, many of these genes were uniformly expressed in most ACE2+ TMPRSS2+ 
cells (Fig 5).  
In the trophectodermal lineage of day 7 blastocysts, 71 cells were negative for both ACE2 and 
TMPRSS2 transcripts whereas 97 cells expressed both the transcripts above the cut-off. Pseudo-bulk 
analysis identified 1452 differentially abundant genes between ACE2+TMPRSS2+ and ACE2–
TMPRSS2– cells. Of these, 1212 genes were present in higher abundance and 240 genes were present 
at lower abundance in the ACE2+TMPRSS2+ cells (Supplementary Table 4). The expression of the 
majority of these genes was homogeneous in the ACE2 and TMPRSS2 co-expressing cells, and 
expression was highly heterogeneous in the non-expressing cells (Fig. 5).  
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Fig.5. Differentially expressed genes in ACE2- and TMPRSS2-positive cells in epiblast and 
trophectodermal cells of developing human blastocysts. (A) Heat map of distribution of 
differentially expressed genes (1985 genes) in ACE2- and TMPRSS2-negative (ACE2–-TMPRSS2–) 
and ACE2- and TMPRSS2-positive (ACE2+-TMPRSS2+) cells of the epiblast. (B) Heat map of 
distribution of 1452 differentially expressed genes in ACE2–-TMPRSS2– and ACE2+TMPRSS2+ 
trophectodermal cells. In A and B rows represent genes and columns represent individual cells, 
presented on a relative color scale. (C) Expression of TMPRSS4, TMPRSS13, CTSB and CTSL in 
ACE2─TMPRSS2─ and ACE2+TMPRSS2+ cells of  epiblast (D) Expression of TMPRSS4, 
TMPRSS13, CTSB and CTSL in ACE2─TMPRSS2─ and ACE2+TMPRSS2+ cells of trophectoderm. 
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Significantly different (p<0.05) mean values are marked as *. Data were extracted from single-cell 
RNA-Seq of the epiblast of developing human embryos (Stirparo et al., 2018), trophectoderm data 
was extracted from (Petropoulos et al., 2016).   
In both epiblast and trophectodermal cells, the ACE2+TMPRSS2+ cells were also enriched for other 
S protein cleavage enzymes. In the epiblast and day 7 trophectoderm, TMPRSS4, TMPRSS13, CTSB 
and CTSL transcripts were present in significantly higher abundance in the ACE2+TMPRSS2+ cells 
as compared to the cells that did not express either of the two genes (p-value <0.05). Many other 
members of the TMPRSS and Cathepsin family were also enriched in the ACE2+TMPRSS2+ cells, 
although many did not reach statistical significance (Supplementary Fig. 2) 
Comparative analysis of the differentially abundant transcripts identified 216 genes that were 
common in both the epiblast and day 7 trophectodermal lineage, while 1768 genes were unique to 
epiblast and 1236 genes were unique to the trophectodermal lineage (Fig. 6). The list of these genes 
is given in Supplementary Table 5.    
The biological processes associated with the 216 common genes involved sterol, alcohol and 
cholesterol metabolism and localization; the enriched KEGG pathways included lysosome and 
steroid biosynthesis (Fig. 6). The genes unique to epiblast cells involved biological processes 
associated with embryonic development and energy metabolism; enriched KEGG pathways included 
oxidative phosphorylation and small molecule metabolism (Fig. 6). The genes unique to the 
trophectoderm lineage involved biological processes associated with glycolipid metabolism, 
liposaccharide metabolism, and leukocyte activation; enriched KEGG pathways included lysosome, 
peroxisome, glycan degradation and herpes simplex virus infection (Fig. 6).  
 
 
 
 
 
 
18 
 
 
 
 
Fig.6. Biological processes enriched in ACE2- and TMPRSS2-positive cells in epiblast and day 7 
trophectodermal cells of developing human blastocysts. (A) Venn diagram showing numbers of 
differentially abundant genes unique and common in ACE2- and TMPRSS2- positive cells vs ACE2- 
and TMPRSS2-negative cells in day 7 trophectodermal (D7 TE) cells and epiblast cells of human 
embryos.  Biological processes enriched in the differential abundant genes of the epiblast (B) and 
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day 7 TE (C). The Y axis indicates the enriched biological processes and X axis is –Log10 adjusted 
P value. Hatched bar are terms of the KEGG pathways, the solid bars represent the biological 
processes. Data were extracted from single-cell RNA-Seq of the epiblast of developing human 
embryos (Stirparo et al., 2018) . Data for day 7 (D7) blastocyst trophectodermal cells was extracted 
from (Petropoulos et al., 2016) 
 
Discussion 
The results of the present study demonstrate that early human embryos express coronavirus entry 
receptors and S protein proteases. The embryonic cells also expressed the genes for proteins that are 
involved in viral endocytosis and replication.  
Considering the scale at which the SARS-CoV-2 virus has spread globally and the fact that a 
proportion of individuals harbouring the virus are asymptomatic, it is likely that some of the infected 
individuals may have conceived or are trying to conceive during the duration of the pandemic. 
Further, with nearly 1 in 6 couples facing infertility, many would resort to in vitro fertilization (IVF) 
techniques for achieving biological parenthood during the pandemic. In both these scenarios, it is 
imperative to understand whether the developing embryo is at risk for SARS-CoV-2 infection. To 
address this question, we analysed single-cell RNA-Seq datasets of developing human embryos for 
SCARFs in zygotes to hatched blastocysts. Our results reveal that gametes, zygotes, and 4-cell 
embryos express ACE2 and BSG along with CTSL but not TMPRSS2. While the levels of ACE2 
decline in the compact morula, the expression of ACE2 and the S protein processing enzymes 
increases in the ICM and epiblast of the blastocyst embryos. Along with the cells of the embryo 
proper, we also detected abundant expression of these genes in the trophectodermal lineage of the 
blastocysts. Although ACE2 is essential for SARS-CoV-2 infection, the processing of the viral spike 
protein by the membrane-bound serine protease TMPRSS2 promotes viral infectivity. We observed 
that even though more than 80% of cells of the ICM express ACE2, none of these cells express 
TMPRSS2. However, in the epiblast (but not the primitive endoderm) and the trophectodermal cells 
of the blastocysts, a significant proportion of cells co-express ACE2 and TMPRSS2, indicating that 
the early embryonic cells may be permissible to viral entry by the canonical ACE2 mode of entry.  
Beyond ACE2, a study has shown that the extracellular matrix metalloproteinase enhancer, CD147, 
encoded by the gene BSG binds to both SARS-CoV-2 and SARS-CoV, promoting viral entry 
independent of ACE2 and TMPRSS2 (Chen et al., 2005; Wang et al., 2020). We observed that BSG 
transcripts were abundantly expressed in all the cells of the developing embryos from the zygote 
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stage to blastocyst stage including the trophectodermal lineage. With regard to S protein priming, 
cathepsins are a class of endosomal proteases, and of these, cathepsin L encoded by CTSL is required 
for endosomal cleavage of SARS-CoV and SARS-CoV-2 spike proteins (Hoffmann et al., 2020). 
Interestingly, along with BSG, CTSL was co-expressed in most of the cells of the developing embryo. 
In a subset of cells of the blastocyst cell stage, embryos also co-expressed ACE2 and BSG.  
Presently, it is unclear if CD147-mediated viral entry requires cathepsin L or TMPRSS2; the fact that 
both these proteins are co-expressed in most trophectodermal cells as well as epiblast cells imply that 
both canonical and non-canonical modes of SARS-CoV-2 entry may be operative in developing 
embryos.   
Two other members of the coronavirus family that are highly infectious and can cause significant 
mortality are MERS and HCoV-229E. Unlike SARS-CoV and SARS-CoV-2, MERS and HCoV-
229E utilize DPP4 and ANPEP as receptors to infect the human host cells (Li, 2015). Interestingly, 
we found that DPP4 and ANPEP transcripts are not expressed in the zygotes until the morula stage, 
but both receptors are expressed in almost all the cells of the ICM, epiblast, and early endoderm. 
Together our data for the first time suggest that early human embryos could be permissive to SARS-
CoV-2 and other coronaviruses; embryos at the blastocyst stage may be most susceptible to 
infection. It will be of interest to study the protein expression of these genes in these cell types and 
experimentally determine the effects of SARS-CoV-2 (and other coronaviruses) on blastocyst health.    
During development, the cells of the embryo proper are enveloped by a layer of trophectodermal 
cells that form the placenta. The placenta is a key determinant of the health of the developing fetus 
and protects it from maternal infections. We and others have shown that the trophoblast cells of the 
human placenta in the first to third trimester express SCARFs, suggesting that the placenta may be 
permissive to SARS-CoV-2 infection (Ashray et al., 2020; Singh et al., 2020b). Extending these 
findings, herein we show that the trophectodermal cells that are the precursors of the placenta 
abundantly express the SCARFs as early as day 5 when they make their first morphologic 
appearance. Furthermore, we also observed that unlike in the case of the placenta, where 5-15% of 
the trophoblasts express ACE2 and TMPRSS2 (Ashray et al., 2020), almost all the cells of the 
trophectoderm co-express both these factors. Similarly, almost all the trophectodermal cells of the 
blastocysts co-transcribe the non-canonical receptor CD147 and the S protein protease CTSL along 
with other coronavirus receptors ANPEP and DPP4. These results indicate that the trophectoderm of 
early human embryos may be highly permissive to multiple coronaviruses.    
Once the virus binds to the receptor and the spike protein undergoes cleavage, SARS-CoV-2 releases 
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its content into the host cells and initiates replication. At this point of the viral infectious cycle, most 
enveloped viruses recruit the ESCRT machinery of the host cell. The viral structural protein engages 
the tumour susceptibility gene protein (TSG101) in ESCRT-I, which subsequently delivers ESCRT-
III to sites of viral budding where membrane scission releases new viral particles (Votteler and 
Sundquist, 2013). Several proteins are involved in the ESCRT pathway, and blocking any of these 
enzymes can prevent viral endocytosis (Wang et al., 2017; Mazzon and Marsh, 2019). Whether 
coronaviruses utilize ESCRT for endocytosis and budding is unknown but there is some evidence for 
the SARS-CoV-2 proteins interacting with human proteins of ESCRT pathway (Gordon et al., 2020; 
Maaroufi, 2020). Thus, we postulated that for SARS-CoV-2 to be pathogenic to human embryos, the 
early embryonic cell must possess the components of the ESCRT machinery for viral endocytosis 
and release. Interestingly, we observed that genes for many components of the ESCRT machinery 
are not expressed in zygote and morula stages, but a surge in the expression of these genes occurs in 
the cells of the blastocyst including the ICM, epiblast, and primitive endoderm and most abundantly 
in the cells of the trophectoderm. These results indicate that the human blastocysts expressing SARS-
CoV-2 receptors not only have the necessary machinery for viral attachment onto the cell surface but 
also readily express the infrastructure to facilitate endocytosis and viral budding. 
Once the virus enters the cells, the next step in the infectious cycle is replication, which requires 
interaction of the viral proteins with host proteins (de Wilde et al., 2018). Our results reveal that as 
compared to the zygote, 4- to 8-cell stages, and morula stage embryos, the cells of the blastocyst 
show a surge in mRNA expression of most host proteins involved in viral replication. Almost all of 
the proteins involved in viral replication were abundantly expressed in the ICM, epiblast, and 
primitive endoderm with the highest expression in the trophectoderm. Together our data show that 
early developing human embryos have the necessary machinery to facilitate viral replication.  
Our analysis, so far, suggests that several genes involved in endocytosis and viral replication are 
expressed in the cells of developing embryos. However, it remains imperative to determine if all or a 
subset of the cells express these genes. Since most ACE2- and TMPRSS2-positive cells were present 
in the epiblast and the trophectoderm, we analysed the data at single-cell resolution and observed that 
irrespective of the expression of ACE2 and TMPRSS2, cells of the epiblast and trophectoderm have 
transcripts of genes involved in viral endocytosis and replication, albeit with varying degrees of 
expression. These genes were also uniformly expressed in cells of the early ICM and the primitive 
endoderm (not shown). These results imply that along with the trophectoderm and epiblast, the other 
cells of the blastocyst could be susceptible to SARS-CoV-2 infection.  
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Once the viral RNA enters the host cells, it translates several of its non-structural proteins, which in 
turn physically interact with various host proteins to regulate host cell machinery. There are 332 
human proteins that physically interact with SARS-CoV-2 (Gordon et al., 2020). These proteins have 
a wide range of functional roles in host cellular processes such as DNA replication, vesicle 
trafficking, lipid modification, RNA processing and regulation, nuclear transport machinery, 
cytoskeletal organization, mitochondrial functions, and extracellular matrix modelling (Gordon et al., 
2020). We observed that mRNA of genes encoding for the SARS-CoV-2 interacting proteins are 
expressed in most cells of the ICM, primitive endoderm, and the epiblast; the mRNA levels of these 
genes were also high in the cells of the trophectodermal lineage. Together our observations imply 
that in human embryos, a high proportion of genes representing protein products that interact with 
SARS-CoV-2 are expressed in the cells of the embryo proper and even more so in the 
trophectoderm.   
In developing embryos, the health of the cells of the epiblast and trophectoderm are crucial as these 
cells subsequently undergo gastrulation and placentation, respectively. Any damage to these cells, 
physically or functionally, may lead to embryo lethality or organ dysfunctions in later development. 
To understand the molecular characteristics of the SARS-CoV-2 permissive cells, we analysed the 
gene signature of the ACE2+TMPRSS2+ epiblast and day 7 trophectodermal cells. We identified 
1985 genes in the epiblast that were differentially expressed between the ACE2- and TMPRSS2-
positive cells and ACE2- and TMPRSS2-negative cells; 1452 genes were differentially abundant in 
the trophectodermal lineage. Unique gene signatures of ACE2-positive cells have also been reported 
for other tissues (Seow et al., 2020; Xu et al., 2020; Ziegler et al., 2020). Amongst the overabundant 
genes in the ACE2+TMPRSS2+ epiblast and trophectoderm cells were cathepsins (including CTSL) 
and members of the TMPRSS family, some of which are required for SARS-CoV-2 S protein 
cleavage (Hoffmann et al., 2020; Shang et al., 2020a; Zang et al., 2020). Beyond the proteases, 
mRNA levels of several other proteins such as TROP2 (also known as TACSTD2) were also detected 
in higher abundance in the ACE2+TMPRSS2+ cells of the epiblast and trophectoderm. In the adult 
human liver, the highest expression of ACE2 and TMPRSS2 are detected in TROP2-positive cells, 
and viral infection of the TROP2+ progenitors may be a cause of hepatic failure in patients with 
COVID-19 (Seow et al., 2020). These observations imply that the ACE2+TMPRSS2+ cells could 
have a unique profile of genes that could aid in viral infectivity and pathogenesis of COVID-19. 
Single-cell RNA-Seq has revealed that in developing human embryos, the inner cell mass and 
trophectoderm segregate on day 5 of development, the trophectodermal lineage progressively gets 
specified, and by day 7 two distinct sub-populations of trophectoderm become evident (Petropoulos 
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et al., 2016). In contrast, the epiblast retains pluripotency, and transcriptomic hallmarks of self-
renewal are observed well until day 7 (Singh et al., 2019). Despite such developmental divergence, 
we observed that the ACE2+TMPRSS2+ cells of the epiblast and trophectoderm shared a unique 
gene signature. The biological processes associated with the common genes involved sterol, alcohol, 
and cholesterol metabolism, and the steroid biosynthesis KEGG pathway was enriched. Host cell 
fatty acid synthesis machinery plays a crucial role in viral genome replication and virion production, 
and accumulation of sterols allows for production of secluded membranes for viral replication, which 
shields viral nucleic acids from immune surveillance (Mayer et al., 2019). In the context of 
coronaviruses, a fine-tuned host lipid profile is essential to achieve optimal viral replication (Yan et 
al., 2019). Along with lipid metabolism, the common genes in the ACE2+TMPRSS2+ cells of the 
epiblast and trophectoderm are also enriched in lysosomes and lysosomal proteases. Endosome-
lysosome fusion profoundly promotes infection, and lysosomal proteases are an important 
determinant of the species and tissue tropism of coronaviruses (Burkard et al., 2014; Zheng et al., 
2018). Furthermore, genes in endocytosis and lysosome pathways are highly enriched in cells of the 
lungs of patients with COVID-19 (Xiong et al., 2020) and lysosomotropic drugs like 
hydroxychloroquine and others have potential for anti-SARS-CoV-2 activity (Gordon et al., 2020; 
Sarma et al., 2020). Thus, it appears that the ACE2+TMPRSS2+ cell subsets in the developing 
embryo have a milieu conducive for viremia.   
The ACE2+TMPRSS2+ cells of the trophectoderm and epiblast also had unique gene signatures. In 
the trophectoderm pathways of herpes simplex viral infection, glycan modifications and peroxisomes 
were enriched. Glycans are essential components of viruses including SARS-CoV-2 and play a key 
role in their pathogenesis (Fanibunda et al., 2011; Watanabe et al., 2020). Peroxisomes are 
multifunctional organelles with roles in cellular metabolism and signalling; some virus-host 
interactions rewire host peroxisomes to support viral replication and spread (Lazarow, 2011). The 
role of host glycan modifications and peroxisome machinery in SARS-CoV-2 pathogenesis is yet to 
be understood; it is tempting to propose that since these pathways are enriched in the 
ACE2+TMPRSS2+ cells, it will be worth exploring these processes for identifying novel drugs for 
SARS-CoV-2. In the epiblast, the unique genes in ACE2+TMPRSS2+ cells, as expected, had roles in 
cellular organization for embryonic development, which also included enriched genes in oxidative 
phosphorylation. A higher expression of genes involved in metabolic pathways including oxidative 
phosphorylation is reported in neutrophils of COVID-19 patients (Gardinassi et al., 2020; Singh et 
al., 2020a). Together the results imply a possible role of mitochondrial activity in SARS-CoV-2 
infection.   
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Thus, our analyses reveal that the ACE2- and TMPRSS2-positive cells in the epiblast and 
trophectoderm are enriched for genes involved with lipid metabolic pathways and lysosomes; the 
trophectoderm cells specifically are enriched for genes involved in the peroxisome while the epiblast 
cells are enriched for genes involved in mitochondrial functions. Since all these processes are 
utilized by viruses (including coronaviruses), it is tempting to propose that the coronaviruses have 
adapted to optimize access to the host cells that are highly permissive for viral propagation, and in 
different tissues, multiple pathways could be utilized for their spread.  
Viral infections in pregnancy are associated with adverse outcomes such as miscarriages, stillbirths, 
and congenital abnormalities (Adams Waldorf et al., 2018). Preimplantation embryos are considered 
to be protected because the zona pellucida acts as a barrier that reduces the susceptibility of 
embryonic cells to viral infection. However, reduced survival of zona-intact mouse embryos is 
observed upon exposure to Zika viruses (Tan et al., 2019; Block et al., 2020), suggesting that the 
zona pellucida may be more vulnerable than it is believed to be. In addition, the Zika virus has been 
shown to infect the trophectoderm and ICM of preimplantation embryos that express the Zika 
receptors, and exposure of early preimplantation embryos to Zika viruses compromises fetal brain 
development (Tan et al., 2019). Extrapolating from these observations and the fact that cells of the 
embryo proper and the trophectoderm are potentially permissive to viral entry, it is plausible that 
SARS-CoV-2 and other coronaviruses may also have embryo-toxic effects. Indeed, ACE2  and 
TMPRSS2, which are highly expressed in the developing trophectoderm, are also expressed in the 
human placental cells, and virions are detected in the trophoblast cells of the placenta from a 
pregnant women with COVID-19 (Ashray et al., 2020; Hosier et al., 2020; Vivanti et al., 2020). 
Further, placental damage is observed in pregnancies complicated by SARS-CoV-2 infection 
(Bahadur et al., 2020; Verma et al., 2020). While it will be impossible to generate data on the long-
term consequences of SARS-CoV-2 infection in human embryos, clinicians and patients seeking 
fertility options via in vitro fertilization specifically must be aware of the potential negative impact 
of SARS-CoV-2 on early developing embryos.     
Overall, this study provides a roadmap for future studies on embryo-toxic effects of SARS-CoV-2 
and other coronaviruses. While this is the first in-depth survey of SCARF expression in developing 
human embryos, it is limited by the constraints and shortcomings of scRNA-seq. These include 
under-representation of rare cell types, isolation biases, and statistical cutoffs. Furthermore, RNA 
expression levels do not always accurately reflect protein abundance; therefore, our observations 
must be corroborated for protein expression in situ. Also, SCARF expression may be modulated by 
co-infection of SARS-CoV-2 and other pathogens, resulting in completely diverse consequences. 
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Nevertheless, our study provides valuable baseline data on SCARFs in developing human embryos, 
which may prove to be a useful resource in the context of not just SARS-CoV-2 but also other viral 
infections in general. This knowledge will be useful to clinics performing IVF procedures during the 
COVID-19 pandemic in order to develop evidence-based guidelines for patient management.  
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Supplementary Fig 1: mRNA levels of  Endosomal Complexes Required for Transport 
(ESCRT), viral replication and SARS-CoV-2 interactions in single cells of epiblast (A) and 
trophectoderm (B).  . In all heat maps, each row depicts a gene and each column depicts a single 
cell. The  ACE2+TMPRSS2+ are cells co-expressing both these genes and ACE2-TMPRSS2-  are 
cells  express neither. Data is presented in relative color scale. Single-cell RNA-Seq of epiblasts was 
extracted from (Stirparo et al., 2018) and trophectoderm cells from (Petropoulos et al., 2016).  
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Supplementary Fig 2: Heat maps for  expression of Cathepsin (CTS) family and TMPRSS 
family genes in  Epiblast (A) and Day 7 trophectoderm  (B). .Each row depicts a gene and each 
column is pseudo-bulk data of single cell. Data is presented in relative color scale. Single-cell RNA-
Seq of epiblasts was extracted from (Stirparo et al., 2018) and trophectoderm cells from (Petropoulos 
et al., 2016).  
 
